BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26420945)

  • 1. Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety.
    Kumar R; Gupta S; Kaur A; Gupta M
    Asian J Transfus Sci; 2015; 9(2):199-202. PubMed ID: 26420945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of viral markers testing by ELISA and Individual Donation Nucleic Acid Testing (ID-NAT) for blood screening in blood bank: Single center study in Egypt.
    Attia FM; Farouk AM; Abdelhady SA
    Egypt J Immunol; 2024 Apr; 31(2):55-60. PubMed ID: 38615235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety.
    Chigurupati P; Murthy KS
    Asian J Transfus Sci; 2015; 9(1):9-11. PubMed ID: 25722565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Donation Screening of Transfusion-Transmissible Viral Infection Using Two Different Nucleic Acid Testing (NAT) Platforms: A Single Tertiary Care Oncology Centre Experience.
    Pathak A; Panda D; Sharma M; Tejwani N; Mehta A
    Indian J Hematol Blood Transfus; 2023 Jul; 39(3):456-463. PubMed ID: 37304490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need for nucleic Acid testing in countries with high prevalence of transfusion-transmitted infections.
    Jain R; Aggarwal P; Gupta GN
    ISRN Hematol; 2012; 2012():718671. PubMed ID: 23008779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Trends of Hepatitis C, Hepatitis B, and Human Immunodeficiency Viruses Over Half a Decade Among Healthy Blood Donors Across Sindh, Pakistan.
    Jamal DE; Waheed S; Gul S; Ali M
    Cureus; 2024 Apr; 16(4):e58374. PubMed ID: 38756311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International review of blood donation nucleic acid amplification testing.
    Faddy HM; Osiowy C; Custer B; Busch M; Stramer SL; Adesina O; van de Laar T; Tsoi WC; Styles C; Kiely P; Margaritis A; Kwon SY; Qiu Y; Deng X; Lewin A; Jørgensen SW; Erikstrup C; Juhl D; Sauleda S; Camacho Rodriguez BA; Coral LJCS; Gaviria García PA; Oota S; O'Brien SF; Wendel S; Castro E; Navarro Pérez L; Harvala H; Davison K; Reynolds C; Jarvis L; Grabarczyk P; Kopacz A; Łętowska M; O'Flaherty N; Young F; Williams P; Burke L; Chua SS; Muylaert A; Page I; Jones A; Niederhauser C; Vermeulen M; Laperche S; Gallian P; Sawadogo S; Satake M; Gharehbaghian A; Addas-Carvalho M; Blanco S; Gallego SV; Seltsam A; Weber-Schehl M; Al-Riyami AZ; Al Maamari K; Alawi FB; Pandey HC; Mbanya D; França RA; Charlewood R;
    Vox Sang; 2024 Apr; 119(4):315-325. PubMed ID: 38390819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international review of the characteristics of viral nucleic acid-amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT.
    Faddy HM; Osiowy C; Custer B; Busch M; Stramer SL; Dean MM; Acutt J; Viennet E; van de Laar T; Tsoi WC; Styles C; Kiely P; Margaritis A; Kwon SY; Qiu Y; Deng X; Lewin A; Jørgensen SW; Erikstrup C; Juhl D; Sauleda S; Camacho Rodriguez BA; Soto Coral LJC; Gaviria García PA; Oota S; O'Brien SF; Wendel S; Castro E; Navarro Pérez L; Harvala H; Davison K; Reynolds C; Jarvis L; Grabarczyk P; Kopacz A; Łętowska M; O'Flaherty N; Young F; Williams P; Burke L; Chua SS; Muylaert A; Page I; Jones A; Niederhauser C; Vermeulen M; Laperche S; Gallian P; Satake M; Addas-Carvalho M; Blanco S; Gallego SV; Seltsam A; Weber-Schehl M; Al-Riyami AZ; Al Maamari K; Alawi FB; Pandey HC; França RA; Charlewood R;
    Vox Sang; 2024 Mar; ():. PubMed ID: 38516962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removing hepatitis C antibody testing for Australian blood donations: A cost-effectiveness analysis.
    Cheng Q; Hoad VC; Roy Choudhury A; Seed CR; Bentley P; Shih STF; Kwon JA; Gray RT; Wiseman V
    Vox Sang; 2023 Jun; 118(6):471-479. PubMed ID: 37183482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Plasmodium spp. in asymptomatic blood donors by the new Brazilian NAT PLUS HIV/HBV/HCV/Malaria Bio-Manguinhos kit.
    Costa E; Rocha D; Lopes JIF; Andrade E; Cardoso P; Ribeiro M; Fontana-Maurell M; Vicentino ARR; Calazans AR; Arruda MB; Mesquita CA; Ferreira AGP; Amorim Filho L; Alvarez P
    Transfusion; 2024 Mar; 64(3):501-509. PubMed ID: 38258881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Evaluation of Nucleic Acid Testing for Screening of Blood Donations for Thalassemia Patients (ECONAT) in Western India.
    Anne PB; Gupta A; Misra S; Sharma SK; Garg MK; Bajpayee A; Bundas S; Bohra M; Asirvatham V
    Indian J Hematol Blood Transfus; 2023 Apr; 39(2):317-324. PubMed ID: 37006984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HIV, hepatitis B and hepatitis C infections among patients with thalassemia attending a tertiary care (rural) hospital.
    Mandal TK; Sarkar S; Haldar P; Mondal S; Chatterjee SS; Paul P; Ray R; Ghosh RR; Saha S; Dan U
    J Family Med Prim Care; 2024 May; 13(5):1780-1786. PubMed ID: 38948618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in a French Administrative Detention Centre.
    Mancy S; Fabbro-Peray P; Alonso S; Berkaoui H; Lambremon L; Vidal H; Hilaire C; Herrmann D; Dapoigny J; Kinné M
    J Epidemiol Glob Health; 2024 May; ():. PubMed ID: 38739355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a multiplex polymerase chain reaction assay for detection of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus 1.
    Nemr WA; Nashwa RK
    World J Virol; 2024 Mar; 13(1):88164. PubMed ID: 38616859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of virus transmission through femoral head allografts: A Belgian appraisal.
    Traore A; Yombi JC; Tribak K; Cornu O
    J Clin Orthop Trauma; 2013 Sep; 4(3):119-22. PubMed ID: 26403550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manually-Operated, Slider Cassette for Multiplexed Molecular Detection at the Point of Care.
    Seok Y; Yin Q; Li R; Mauk MG; Bai H; Bau HH
    Sens Actuators B Chem; 2022 Oct; 369():. PubMed ID: 38756788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality and Safety in Blood Supply in 2010.
    Seitz R; Heiden M
    Transfus Med Hemother; 2010 Jun; 37(3):112-117. PubMed ID: 20577599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus detection using nanoparticles and deep neural network-enabled smartphone system.
    Draz MS; Vasan A; Muthupandian A; Kanakasabapathy MK; Thirumalaraju P; Sreeram A; Krishnakumar S; Yogesh V; Lin W; Yu XG; Chung RT; Shafiee H
    Sci Adv; 2020 Dec; 6(51):. PubMed ID: 33328239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. "Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country" [Transfus Med Hemother. 2019 Apr;46(2):104-10].
    Styles CE; Cheng A; Hoad VC; Kiely P; Watson M; Seed CR
    Transfus Med Hemother; 2020 Jun; 47(3):272-274. PubMed ID: 32595432
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV risk associated with nucleic acid testing tested seronegative blood donation where the donor was not preassessed for the risk.
    Ghosh K; Misra K
    Asian J Transfus Sci; 2017; 11(2):213-214. PubMed ID: 28970697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.